MC

Mark Christopher Engel

Active Director Director DIN 11239609
DIN 11239609 First appointment Aug 2025 Primary industry Biotechnology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Mark Christopher Engel

Data last updated:

Mark Christopher Engel is a Director at Phagelux Agrihealth (India) Private Limited (since 2025) and Director at Precisio Biotix Therapeutics (India) Private Limited (since 2025). The companies operate in Biotechnology.

DIN 11239609
Primary Designation Director
Industry Biotechnology
First Appointment 12 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Aug 20252025Active
Director12 Aug 20252025Active

Board colleagues of Mark Christopher Engel

Directorship timeline

Open interactive timeline →
Phagelux Agrihealth (India) Private Limited
Precisio Biotix Therapeutics (India) Private Limited
Premium access

Shareholding and investment profile for Mark Christopher Engel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mark Christopher Engel

Mark Christopher Engel currently holds 2 directorships: Phagelux Agrihealth (India) Private Limited (Director, since 25 Aug 2025); Precisio Biotix Therapeutics (India) Private Limited (Director, since 12 Aug 2025).

Mark Christopher Engel was first appointed on 12 Aug 2025 as Director at Precisio Biotix Therapeutics (India) Private Limited.

The current boards of Mark Christopher Engel's companies include Bhushan Nandkishor Bhavsar (Phagelux Agrihealth (India) Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available